| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.979 | 5.888 | 6.436 | 6.181 | 6.893 | 6.580 | 8.167 | 9.693 | 8.717 | 9.500 |
| Total Income - EUR | 4.979 | 5.888 | 6.436 | 6.181 | 6.893 | 6.580 | 9.407 | 10.031 | 9.098 | 9.556 |
| Total Expenses - EUR | 2.572 | 3.571 | 2.586 | 2.714 | 3.451 | 2.827 | 6.150 | 3.355 | 4.184 | 4.151 |
| Gross Profit/Loss - EUR | 2.406 | 2.317 | 3.850 | 3.467 | 3.442 | 3.753 | 3.258 | 6.676 | 4.914 | 5.405 |
| Net Profit/Loss - EUR | 2.257 | 2.140 | 3.657 | 3.281 | 3.235 | 3.621 | 3.135 | 6.391 | 4.144 | 4.557 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Selif - Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 730 | 394 | 56 | 0 |
| Current Assets | 2.312 | 2.315 | 3.711 | 3.335 | 3.334 | 3.671 | 3.240 | 6.496 | 4.315 | 4.841 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 971 | 0 | 0 | 0 | 0 |
| Receivables | 29 | 30 | 145 | 141 | 137 | 39 | 0 | 0 | 0 | 0 |
| Cash | 2.283 | 2.285 | 3.566 | 3.194 | 3.198 | 2.660 | 3.240 | 6.496 | 4.315 | 4.841 |
| Shareholders Funds | 2.311 | 2.194 | 3.710 | 3.333 | 3.285 | 3.671 | 3.183 | 6.440 | 4.192 | 4.605 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1 | 122 | 1 | 2 | 49 | 0 | 57 | 56 | 122 | 236 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 730 | 394 | 56 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Selif - Med Srl